IntelliPharmaCeutics International Inc (IPCIF)
0.10
+0.08
(+369.48%)
USD |
OTCM |
Jun 03, 15:42
IntelliPharmaCeutics International Total Assets (Quarterly): 1.566M for Aug. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2023 | 1.566M |
| May 31, 2023 | 1.735M |
| February 28, 2023 | 1.595M |
| November 30, 2022 | 1.432M |
| August 31, 2022 | 1.437M |
| May 31, 2022 | 1.882M |
| February 28, 2022 | 1.890M |
| November 30, 2021 | 2.096M |
| August 31, 2021 | 3.457M |
| May 31, 2021 | 4.979M |
| February 28, 2021 | 2.683M |
| November 30, 2020 | 3.387M |
| August 31, 2020 | 4.217M |
| May 31, 2020 | 3.563M |
| February 29, 2020 | 3.604M |
| November 30, 2019 | 3.797M |
| August 31, 2019 | 4.163M |
| May 31, 2019 | 5.568M |
| February 28, 2019 | 7.552M |
| November 30, 2018 | 11.47M |
| August 31, 2018 | 5.634M |
| May 31, 2018 | 6.668M |
| February 28, 2018 | 5.392M |
| November 30, 2017 | 7.397M |
| August 31, 2017 | 6.658M |
| Date | Value |
|---|---|
| May 31, 2017 | 7.780M |
| February 28, 2017 | 7.960M |
| November 30, 2016 | 7.975M |
| August 31, 2016 | 5.368M |
| May 31, 2016 | 3.819M |
| February 29, 2016 | 3.814M |
| November 30, 2015 | 5.224M |
| August 31, 2015 | 6.220M |
| May 31, 2015 | 6.642M |
| February 28, 2015 | 7.315M |
| November 30, 2014 | 7.875M |
| August 31, 2014 | 9.015M |
| May 31, 2014 | 11.00M |
| February 28, 2014 | 10.45M |
| November 30, 2013 | 4.380M |
| August 31, 2013 | 4.113M |
| May 31, 2013 | 3.608M |
| February 28, 2013 | 2.551M |
| November 30, 2012 | 2.475M |
| August 31, 2012 | 4.953M |
| May 31, 2012 | 6.913M |
| February 29, 2012 | 4.402M |
| November 30, 2011 | 6.247M |
| August 31, 2011 | 9.026M |
| May 31, 2011 | 10.56M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.432M
Minimum
Nov 2022
4.979M
Maximum
May 2021
2.793M
Average
2.683M
Median
Feb 2021
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 6.475M |
| Lexaria Bioscience Corp | 6.352M |
| Xenon Pharmaceuticals Inc | 919.02M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 14.44M |
| Shareholders Equity (Quarterly) | -12.88M |
| Debt to Equity Ratio | -0.1689 |
| Current Ratio | 0.0597 |
| Net Debt Paydown Yield | -1.59% |